Graham Holdings Company remains a buy, supported by attractive valuation, strong balance sheet, and significant breakup value potential. GHC's diversified segments showed mixed results, with notable revenue growth in healthcare, broadcasting, and manufacturing, but some margin pressure in several divisions. Sum-of-the-parts analysis suggests 16.3% to 82.4% upside if GHC's segments are valued independently, leveraging peer multiples and net cash.








